Published date: 5 November 2018

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 12 March 2018

Contract summary

Industry

  • Laboratory, optical and precision equipments (excl. glasses) - 38000000

Location of contract

North East

Value of contract

£335,000

Procurement reference

NCL001-DN310719-87849518

Published date

5 November 2018

Closing date

12 March 2018

Contract start date

1 October 2018

Contract end date

6 December 2021

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The radiochemistry platforms sought, will support ongoing Neuroscience research by facilitating GMPproduction of markers of abnormal protein aggregation (e.g. amyloid, tau, and alpha synuclein) in order to studyin vivo, the pathology of Dementias (Lewy body, Parkinson's Disease, Alzheimer's Disease) and provide proofof mechanism of interventions designed to reverse or remove abnormal oligomers and fibrils - immunotherapy,secretase blockers, anti-aggregants, etc.The tendered platforms will also provide workhorse imaging biomarkers to detect tumours and monitor their function

Award information

Awarded date

1 October 2018

Contract start date

12 October 2018

Contract end date

6 December 2021

Total value of contract

£253,168

This contract was awarded to 1 supplier.

Optimized Radiochemical Applications

Address

Rue de la Gendarmerie 50B
Philippeville
5600
Belgium

Reference

None

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Contact name

Emma Barksby

Address

Newcastle University
Procurement Services, Kingsgate
Newcastle
NE1 7RU
England

Telephone

+44 1912226298

Email

emma.barksby@ncl.ac.uk